MiniMed swings to breakeven net income in Q1 FY27; net sales climb 16.6% to $843 million from year-ago quarter

• MiniMed posted Q1 FY2027 net sales of $843 million, up 16.6% year over year; operating income improved to $5 million from an operating loss.
• Net income attributable to shareholders swung to break-even from a loss; diluted EPS improved to $0.00.
• International net sales climbed 18.1% to $603 million; U.S. net sales rose 13.1% to $240 million.
• Worldwide new pumps sold increased 7.7% to about 34,000; CGM attachment rate edged up 1 percentage point to 69% versus the prior quarter.
• Raised FY2027 organic revenue growth outlook to about 10.5%; CEO Que Dallara cited accelerating U.S. growth and a strong MiniMed Flex launch.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MiniMed Group Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609010645PR_NEWS_USPR_____CG37785) on September 01, 2026, and is solely responsible for the information contained therein.